Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 6

    1.

    Endocrine parameters of cystic fibrosis: Back to basics.

    Stalvey MS, Flotte TR.

    J Cell Biochem. 2009 Oct 1;108(2):353-61.PMID: 19670266 [PubMed - in process]Related articles

    2.

    Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.

    Pashuck TD, Franz SE, Altman MK, Wasserfall CH, Atkinson MA, Wronski TJ, Flotte TR, Stalvey MS.

    Pediatr Res. 2009 Mar;65(3):311-6.PMID: 19047917 [PubMed - indexed for MEDLINE]Related articles

    3.

    Growth hormone therapy improves growth in children with cystic fibrosis related liver disease.

    Stalvey MS, Torrez DM, Hillan J, Gonzalez-Peralta RP, Haafiz A, Rosenbloom AL.

    J Pediatr Endocrinol Metab. 2008 Aug;21(8):793-7.PMID: 18825880 [PubMed - indexed for MEDLINE]Related articles

    4.

    CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes.

    Stalvey MS, Brusko TM, Mueller C, Wasserfall CH, Schatz DA, Atkinson MA, Flotte TR.

    Cytokine. 2008 Oct;44(1):154-9. Epub 2008 Sep 7.PMID: 18778952 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.

    Stalvey MS, Muller C, Schatz DA, Wasserfall CH, Campbell-Thompson ML, Theriaque DW, Flotte TR, Atkinson MA.

    Diabetes. 2006 Jul;55(7):1939-45.PMID: 16804061 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Predictors of control of diabetes: monitoring may be the key.

    Haller MJ, Stalvey MS, Silverstein JH.

    J Pediatr. 2004 May;144(5):660-1.PMID: 15127007 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...